Article
A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering.
Pharmacogenomics - 1 Apr 2016
Leusink Maarten, Maitland-van der Zee Anke H, Ding Bo, Drenos Fotios, van Iperen Erik Pa, Warren Helen R, Caulfield Mark J, Cupples L Adrienne, Cushman Mary, Hingorani Aroon D, Hoogeveen Ron C, Hovingh G Kees, Kumari Meena, Lange Leslie A, Munroe Patricia B, Nyberg Fredrik, Schreiner Pamela J, Sivapalaratnam Suthesh, de Bakker Paul Iw, de Boer Anthonius, Keating Brendan J, Asselbergs Folkert W, Onland-Moret N Charlotte
Abstract excerpt
AIM: To find new genetic loci associated with statin response, and to investigate the association of a genetic risk score (GRS) with this outcome. PATIENTS & METHODS: In a discovery meta-analysis (five studies, 1991 individuals), we investigated the effects of approximately 50000 single nucleotide polymorphisms on statin response, following up associations with p < 1 × 10(-4) (three independent studies, 5314...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
